Milosz Wilczynski

281/289 Rzgowska Str
Lodz, LD 93338, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.

Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.

Journal: Przeglad menopauzalny = Menopause review

Published: December 03, 2025

Adenosarcoma of the uterine cervix - a novel case report and review of the literature.

Adenosarcoma of the uterine cervix - a novel case report and review of the literature.

Journal: Przeglad menopauzalny = Menopause review

Published: May 15, 2025

The clinicopathological role of miRNA-196a and its SNP variant rs11614913 in high-grade ovarian cancer.

The clinicopathological role of miRNA-196a and its SNP variant rs11614913 in high-grade ovarian cancer.

Journal: Przeglad menopauzalny = Menopause review

Published: August 21, 2024

TLR8 and TLR9 gene polymorphisms and the risk of high-grade serous ovarian cancer.

TLR8 and TLR9 gene polymorphisms and the risk of high-grade serous ovarian cancer.

Journal: International journal of biological macromolecules

Published: July 19, 2024

MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.

MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.

Journal: Cells

Published: June 24, 2024

Human papillomavirus infection of the fallopian tube as a potential risk factor for epithelial ovarian cancer.

Human papillomavirus infection of the fallopian tube as a potential risk factor for epithelial ovarian cancer.

Journal: Scientific reports

Published: April 19, 2024

Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.

Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.

Journal: International journal of molecular sciences

Published: December 01, 2023

Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer.

Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: November 13, 2023

High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.

High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.

Journal: Biomedicines

Published: November 12, 2023

Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?

Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?

Journal: Journal of personalized medicine

Published: November 12, 2023

"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.

"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.

Journal: Frontiers in oncology

Published: April 06, 2023

Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC).

Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC).

Journal: Cancers

Published: November 27, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026